Peripheral vascular interventions

On 20 October 2026, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) published an update to the List of implants and invasive medical devices, effective from 1 November 2026. Four new material codes were introduced for intracoronary imaging catheters, radial endobronchial ultrasound probes, and custom-made implants for external aortic support. Notably, the update establishes specific reimbursement for materials used in intracoronary imaging and radial endobronchial ultrasound procedures for the first time in Belgium.

Since June 2026, seven new mini-HTAs have been initiated in Norway, including two MedTech-related assessments in the in vitro diagnostics and cardiovascular areas. These assessments are conducted as part of Norway’s framework for the managed introduction of innovations, known as “New Methods”.

In August 2026, the Finnish Coordinating Center for Health Technology Assessment announced the completion of five rapid hospital HTAs in diagnostic imaging, gastrointestinal, neurovascular, peripheral vascular, and some other fields.

On July 30, 2026, the Swiss Federal Statistical Office (OFS) released the systematic version of the Swiss Classification of Surgical Interventions (CHOP) for 2027. The CHOP classification is now available in German and will come into force on January 1, 2027. Multiple new procedure codes were introduced in various fields, including digital therapeutics, endoscopy, gastrointestinal, obstetrics and gynecology, nephrology and urology, men's health, neuromodulation, orthopedics, and peripheral vascular.

In July 2026, the French National Authority for Health (HAS) published new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following its meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Favorable opinions were issued supporting add-on reimbursement for one new device and an extension of the reimbursed indications for another, in the gastrointestinal and peripheral vascular fields.

In June 2026, the National Institute for Health and Care Research (NIHR) in England released four Med Tech-related assessments in its HTA Journal, which concerned newborn screening for severe combined immunodeficiency, primary endovascular revascularization procedures for chronic limb-threatening ischemia, placental growth factor (PLGF)-based testing for suspected pre-eclampsia, and digital front door technologies before assessment for NHS Talking Therapies.

In April 2026, two HTA agencies working under the Spanish Network of HTA Agencies (RedETS) released several New and Emerging Health Technology Fact Sheets in cardiovascular, dermatology, diagnostic imaging, e-health, in-vitro diagnostics, men’s health, obstetrics and gynecology, peripheral vascular, robotic surgery and some other fields. The purpose of the Fact Sheets is to inform the prioritization of new and emerging technologies for evaluation by RedETS.

As of April 2026, the Dutch Healthcare Institute (ZIN) is working on coverage positions in several areas, including otorhinolaryngology, dentistry, vascular interventional radiology, and gastroenterology fields.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the February 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Favourable opinions were issued on the add-on reimbursement for six new devices and on the extension of indications for two devices, in the cardiovascular, peripheral vascular, and ENT fields.

On January 30, 2026, the Institute for the Hospital Remuneration System (InEK) published the list of innovation funding (NUB) requests submitted by hospitals in 2025. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained a positive status 1.

On November 28, 2025, the entity managing the DRG system in Switzerland, SwissDRG, published the final (billing) version of the 2026 DRG system. In total, 19 new DRGs related to cardiovascular, ENT, gastrointestinal, neurology and neurosurgery, obstetrics and gynecology, orthopedics, and some other fields were introduced. Also, four new add-on reimbursement categories were added.

On November 13, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the 2026 Hybrid DRGs catalog had been approved. A total of 47 new Hybrid DRGs were added, including those for appendectomy, cholecystectomy, as well as minimally invasive procedures on the coronary arteries and peripheral vessels. In the area of orthopedic procedures, Hybrid DRGs have been expanded to include fracture osteosynthesis